Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Re: GDNF letter writing campaign
P-I-E-N-O News Discussion and Search
> Many of the trial doctors have spoken out in support of the patients > requests and have stated publicly that there was not sufficient evidence > of negative side effects to halt the trial or to stop the patients' > treatments. They also questioned Amgen's study design and analysis of the > trial results. That´s right. I heard that some of the patients had been misdiagnosed and there were some Huntington patients among the trial patients. Maryse cg JOhn 75,15 ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:listserv@xxxxxxxxxxxxxxxxxxxx In the body of the message put: signoff parkinsn
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance